North America Contraceptive Devices Market – Growth & Forecast (2024 – 2032)

20-24 years. In the United States, between 2009 and 2013, the proportion of pregnancies that were unintended increased slightly, from 49% to 51%, however, by 2014, the rate decreased to nearly 41%. Moreover, in 2014, contraceptives helped men to avoid about 2 million unintended pregnancies, which would likely have resulted in 900,000 unplanned births and nearly 700,000 abortions. However, from the past few years, the awareness on contraception has contributed to both fall in unwanted pregnancies and also growth in the usage of the contraceptives market.

North America Contraceptive Devices Market Segments Share:

North America contraceptive devices market is categorised into a type which comprises of condoms, diaphragms, cervical caps, sponges, vaginal rings, IUD, and implants. Among them, condoms segment is projected to hold the largest share in the market. Inexpensive, readily accessible, convenient, and no delay in fertility after their use are some of the benefits of using a condom. IUD segment is projected to witness the highest growth rate during the forecast period, and it is trustable, effective and is mainly used by women. By gender, the market is segmented into male and female. By end-users, the market is segmented into hospitals, homecare, gynaecology centres, clinics, ambulatory surgical centres (ASC), and others.

By Geography, USA is projected to hold the largest share in the market due to the rising incidence of unintended pregnancies, and increased use of contraceptive devices. However, Mexico is projected to be the fastest growing market due to growing awareness among people, increased incidence of unintended pregnancies & sexually transmitted diseases and several government initiatives. Favourable family planning policy along with other reimbursement

policies such as the AIDS care policy will positively impact the growth of the market.

North America Contraceptive Devices Market Trends:

• The new agreement expands the access to Pfizer contraceptive, SAYANA press for women most in need in the world’s poorest countries.
• Teva Pharmaceuticals launched a new product called Vagifem1 (estradiol vaginal inserts), ten mcg in the United States and it is one of the contraceptive methods.

North America Contraceptive Devices Market Research Report:

An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.

To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.

Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year

Identifying DROC in the current market and their impact in altering the market dynamics.

Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial analysis with major competitors.

Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.

The major market players, such as

• Bayer Healthcare Pharmaceuticals
• Merck & Co., Inc.
• Pfizer, Inc.
• Johnson & Johnson, Ltd
• Reckitt Benckiser Plc

Along with these companies, there were many other companies considered/cited in the report while analysing the North America contraceptives device market. These companies hold substantial share-owning to the nature of the industry whereas rest of the market shares are marginal chunks to regional and local level manufacturers. Other players have considerable presence owing to its robust brand image, geographical reach and strong customer base.